Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha Sahr

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Pediatric Blood & Cancer|January 17, 2020
Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcomaHadeel Halalsheh, Sue C Kaste, Matthew J Krasin, et al.
Cancer|January 23, 2020
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumorsVictor M Santana, Natasha Sahr, Ruth G Tatevossian, et al.
Scientific Reports|March 17, 2016
Chromatin interactions and candidate genes at ten prostate cancer risk lociMeijun Du, Lori Tillmans, Jianzhong Gao, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical TestingJanice M Riberdy, Sheng Zhou, Fei Zheng, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trialRosa Nguyen, Natasha Sahr, April Sykes, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk NeuroblastomaWayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Annals of Diagnostic Pathology|September 30, 2014
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsKenneth A Iczkowski, Lars Egevad, Jun Ma, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pediatric Blood & Cancer|January 17, 2020
Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcomaHadeel Halalsheh, Sue C Kaste, Matthew J Krasin, et al.
Cancer|January 23, 2020
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumorsVictor M Santana, Natasha Sahr, Ruth G Tatevossian, et al.
Scientific Reports|March 17, 2016
Chromatin interactions and candidate genes at ten prostate cancer risk lociMeijun Du, Lori Tillmans, Jianzhong Gao, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical TestingJanice M Riberdy, Sheng Zhou, Fei Zheng, et al.
Journal for Immunotherapy of Cancer|March 30, 2020
Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trialRosa Nguyen, Natasha Sahr, April Sykes, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignanciesSara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2019
A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk NeuroblastomaWayne L Furman, Sara M Federico, Mary Beth McCarville, et al.
Annals of Diagnostic Pathology|September 30, 2014
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsKenneth A Iczkowski, Lars Egevad, Jun Ma, et al.
Pageof 2